|
Year to Mar 2025
12 months to Mar 31, 2025
|
Year to Mar 2024
12 months to Mar 31, 2024
|
Year to Mar 2023
12 months to Mar 31, 2023
|
|
|---|---|---|---|
| REVENUE | |||
| Net sales | |||
| Other income | |||
| Revenue | |||
| COST OF SALES | |||
| GROSS MARGIN | |||
| EXPENSES | |||
| Amortisation | |||
| Depreciation and amortisation | |||
| Bad debts | |||
| Consulting fees | |||
| Directors fees | |||
| Insurance | |||
| Investor relations and promotion | |||
| Listing and filing fees | |||
| Office Expenses | |||
| Professional fees | |||
| Rent | |||
| Research and development | |||
| Salaries and benefits | |||
| Share-based compensation | |||
| Supplies and materials | |||
| Travel | |||
| Other expenses | |||
| Total expenses, by nature | |||
| Loss before other income (expenses) | |||
| Impairment of exploration and evaluation assets | |||
| Interest income | |||
| Interest expense | |||
| Loss on disposal of equipment | |||
| Other income (expense) | |||
| Premium on flow-through shares | |||
| Income tax credit received | |||
| Government grants | |||
| Total other income | |||
| Total other income (expense) | |||
| Net loss and comprehensive loss for the period | |||
| Basic and diluted net loss per share | |||
| Basic net loss per share | |||
| Diluted net loss per share |
Loading...
